Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy.
Giuseppe ArgenzianoPaolo AmerioMaria Grazia AragoneGinevra BagginiManuela BaldariGianpiero CastelliSimmaco CoppolaAntonio CostanzoRocco De PasqualeMaria-Concetta FargnoliCaterina FotiClaudia GiofrèSerena LemboClaudia LeporatiFrancesco LoconsoleGiovanna MalaraKetty PerisAntonio Giovanni RichettaPaola SavoiaRossana TiberioMassimo TravagliniMaria Teresa UzzautoLuca BianchiPublished in: Patient preference and adherence (2021)
By supporting treatment adherence, the PSOLife CARE Program may have empowered patients to better manage their psoriasis, increasing their satisfaction with treatment and quality of life.
Keyphrases
- quality improvement
- end stage renal disease
- newly diagnosed
- healthcare
- ejection fraction
- palliative care
- type diabetes
- prognostic factors
- peritoneal dialysis
- combination therapy
- ankylosing spondylitis
- metabolic syndrome
- adipose tissue
- patient reported outcomes
- replacement therapy
- weight loss
- atopic dermatitis
- glycemic control